Aniridia type 2 – Talk Bio

Actionable Insights Powered by AI

Biopharma Layoff Tracker 2024: FibroGen, Ajinomoto, AN2 Therapeutics and More Cut Staff

8 months ago talkbio0Tagged Ajinomoto, Aniridia type 2, Biopharma layoffs, Drug Industry, FibroGen, restructuring

Biopharma layoffs, FibroGen, Ajinomoto, AN2 Therapeutics, pharmaceutical industry, job cuts, restructuring

AN2 Therapeutics Cuts 50% of Staff and Discontinues Epetraborole Program for MAC Lung Disease

9 months ago talkbio0Tagged Aniridia type 2, Chagas Disease, Complement Membrane Attack Complex, Epetraborole, Lung diseases, MAC, Melioidosis, Phase II/III Trial, restructuring

AN2 Therapeutics, epetraborole, MAC lung disease, Phase II/III trial, workforce reduction, restructuring, melioidosis, Chagas disease